Quality....It's In Our DNA

VGXI is a full service contract manufacturing organization (CMO) that manufactures DNA plasmids for human clinical trials, virus protection, toxicology studies and pre-clinical research.

Industry News & Updates

Meet VGXI at the 2018 Phacilitate Cell and Gene Therapy World
Will you be attending the Phacilitate conference in January 2018? Meet with representatives from ...
Submit Your Nominations for the 2018 ViE Awards
Nominations are now open for the Vaccine Industry Excellence Awards of the 2018 World Vaccine ...
VGXI Featured in Voyage Houston Article
The Woodlands, TX,  January 03, 2018: Learn more about Dorothy Peterson, VGXI’s VP of ...
GeneOne Life Science Receives Approval for Phase I/IIa MERS-CoV Vaccine Trial in Korea
GeneOne Life Science Receives Approval of IND by the Korean Ministry of Food and Drug Safety ...


New White Paper Released – Stability of Plasmid DNA Products
Stability of Plasmid DNA Products: A Review of the Data For any pharmaceutical product, an ...
New White Paper Released – Calculating your DNA plasmid needs.
Calculating the amount of plasmid DNA needed for a  clinical trial may seem straightforward ...
Second Generation DNA Vaccines and Delivery Methods
Second Generation DNA Vaccines DNA vaccines have come a long way resulting in a second generation ...

VGXI Services

Consistent Process Yields. Consistent Results.

Learn More

FREE White Paper

Single-Use Process Equipment for Biopharmaceutical Manufacturing